The advantages start with your FREE
Go Ahead Rub It In™ card
Save up to $30† and join a free patient support program
If your doctor has already prescribed Voltaren® Gel, you may have received a free value card in your Voltaren Gel Starter Kit. The FREE Go Ahead Rub It In card gives you advantages you can really use. Getting started is simple.
- Present your card to your pharmacist and save up to $30 off your first 3-pack and/or 5-pack prescription of Voltaren Gel
- Go to GoAheadRubItIn.com to register your card for:
- Up to $30 off each of your next 5 prescriptions of Voltaren Gel — additional savings you can really use
- An exciting opportunity to enroll in the Voltaren Gel FREE patient support program — The Go Ahead Rub It In program
†On your eligible prescription. Other restrictions may apply. Up to 6 prescriptions.
Not valid for patients covered under Medicaid, Medicare, or similar state or federal programs. Not valid in MA, except for cash-paying patients.
Only one value card per prescription.
For U.S. Only
 To a friend |
|
 Add this page to your Facebook |
|
 Twitter this page |
|
 Digg this page |
|
 Add as a Del icio us bookmark |
|
 StumbleUpon this page |
Important Safety Information
*Voltaren® Gel is indicated for the relief of the pain of osteoarthritis of joints amenable to topical treatment, such as the knees and those of the hands. Voltaren Gel has not been evaluated for use on the spine, hip, or shoulder.
Cardiovascular Risk
- Nonsteroidal anti-inflammatory drugs (NSAIDs) may cause an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. This risk may increase with duration of use. Patients with cardiovascular disease or risk factors for cardiovascular disease may be at greater risk [see Warnings and Precautions].
- Voltaren Gel is contraindicated for the treatment of perioperative pain in the setting of coronary artery bypass graft (CABG) surgery [see Contraindications].
Gastrointestinal Risk
- NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal. These events can occur at any time during use and without warning symptoms. Elderly patients are at greater risk for serious gastrointestinal events [see Warnings and Precautions].
The most common adverse reactions reported in Voltaren Gel clinical trials were application site reactions in 7% of treated patients. With all NSAIDs there may be an increased risk of serious cardiovascular thrombotic events, myocardial infarction, and stroke, which can be fatal. NSAIDs cause an increased risk of serious gastrointestinal adverse events including bleeding, ulceration, and perforation of the stomach or intestines, which can be fatal.
The use of Voltaren Gel is contraindicated in patients with a known hypersensitivity to diclofenac.
Voltaren Gel should not be administered in patients who have experienced asthma, urticaria, or other allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.
Voltaren Gel should not be used in combination with other oral NSAIDs or aspirin because of the potential for increased adverse effects. Similarly, combined use of Voltaren Gel with other topical products, such as sunscreens and cosmetics, on the same skin area has not been tested and should be avoided because of the potential to alter local tolerability and absorption.
There is a potential for elevation in liver function tests during treatment with diclofenac containing products.
Safety and effectiveness in pediatric patients have not been established.
Please see full Prescribing Information for Warnings and Contraindications.
